BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8793620)

  • 1. An identical effect mediated by thyroid deficiency or oncogene v-erbA in the chick embryo.
    Bachnou N; Saule S; Dieterlen-Lievre F
    Int J Dev Biol; 1996 Apr; 40(2):491-7. PubMed ID: 8793620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative effect of v-myc and v-erbA in the chick embryo.
    Bachnou N; Laudet V; Jaffredo T; Quatannens B; Saule S; Dieterlen-Lièvre F
    Oncogene; 1991 Jun; 6(6):1041-7. PubMed ID: 1676836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenic effects mediated in the avian embryo by one or more oncogenes associated with v-myc.
    al Moustafa AE; Quatannens B; Dieterlen-Lièvre F; Saule S
    Oncogene; 1992 Aug; 7(8):1667-70. PubMed ID: 1630827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcoma and thyroid disorders: a common etiology?
    Merimsky O; Issakov J; Kollender Y; Inbar M; Bickels J; Meller I
    Oncol Rep; 2002; 9(4):863-9. PubMed ID: 12066223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicistronic retroviral vector reveals capacity of v-erbA to induce erythroleukemia and to co-operate with v-myb.
    Casini T; Graf T
    Oncogene; 1995 Sep; 11(6):1019-26. PubMed ID: 7566959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective repression of myoD transcription by v-Myc prevents terminal differentiation of quail embryo myoblasts transformed by the MC29 strain of avian myelocytomatosis virus.
    La Rocca SA; Vannucchi S; Pompili M; Pinney DF; Emerson CP; Grossi M; Tatò F
    Oncogene; 2002 Jul; 21(31):4838-42. PubMed ID: 12101422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
    Andersson ML; Vennström B
    Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart tumors specifically induced in young avian embryos by the v-myc oncogene.
    Saule S; Mérigaud JP; Al-Moustafa AE; Ferré F; Rong PM; Amouyel P; Quatannens B; Stéhelin D; Dieterlen-Lièvre F
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7982-6. PubMed ID: 2825173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of telomerase activity in v-myc-transformed avian cells.
    Falchetti ML; Falcone G; D'Ambrosio E; Verna R; Alemà S; Levi A
    Oncogene; 1999 Feb; 18(7):1515-9. PubMed ID: 10050888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targets of v-myc tumorigenesis in the avian embryo depend on time and not on site of retroviral infection.
    al Moustafa AE; Raes MB; Saule S; Dieterlen-Lièvre F
    Cell Differ Dev; 1988 Nov; 25(2):119-34. PubMed ID: 3208190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
    Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
    EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional cell transformation by doxycycline-controlled expression of the MC29 v-myc allele.
    Oberst C; Hartl M; Weiskirchen R; Bister K
    Virology; 1999 Jan; 253(2):193-207. PubMed ID: 9918878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The major histocompatibility complex of chickens controls the infection of early chicken embryos by MC29 virus.
    Hlozanek I; Corbel C; Dieterlen-Lièvre F
    Virology; 1994 Aug; 203(1):29-35. PubMed ID: 8030281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.
    Urnov FD; Yee J; Sachs L; Collingwood TN; Bauer A; Beug H; Shi YB; Wolffe AP
    EMBO J; 2000 Aug; 19(15):4074-90. PubMed ID: 10921888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles.
    Gavine PR; Neil JC; Crouch DH
    Oncogene; 1999 Dec; 18(52):7552-8. PubMed ID: 10602514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of expression of RA-regulated genes by the oncoprotein v-erbA.
    Ventura-Holman T; Mamoon A; Subauste JS
    Gene; 2008 Dec; 425(1-2):23-7. PubMed ID: 18775481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes.
    Nagl SB; Bunn CF; Allison LA
    J Cell Biochem; 1997 Nov; 67(2):184-200. PubMed ID: 9328824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of MAP kinase signalling in Myc transformed cells and rescue by LiCl inhibition of GSK3.
    Al-Assar O; Crouch DH
    Mol Cancer; 2005 Apr; 4(1):13. PubMed ID: 15811177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300.
    Steinmann S; Schulte K; Beck K; Chachra S; Bujnicki T; Klempnauer KH
    Oncogene; 2009 Jul; 28(26):2446-55. PubMed ID: 19448669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.